- Home
- CGBD vs RXST Comparison
CGBD vs RXST Comparison
Compare CGBD & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGBD
- RXST
- Stock Information
- Founded
- CGBD 2012
- RXST 1997
- Country
- CGBD United States
- RXST United States
- Employees
- CGBD N/A
- RXST N/A
- Industry
- CGBD Finance: Consumer Services
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CGBD Finance
- RXST Health Care
- Exchange
- CGBD Nasdaq
- RXST Nasdaq
- Market Cap
- CGBD 1.0B
- RXST 1.0B
- IPO Year
- CGBD 2017
- RXST 2021
- Fundamental
- Price
- CGBD $13.67
- RXST $13.06
- Analyst Decision
- CGBD Hold
- RXST Buy
- Analyst Count
- CGBD 3
- RXST 10
- Target Price
- CGBD $14.00
- RXST $38.50
- AVG Volume (30 Days)
- CGBD 404.4K
- RXST 1.1M
- Earning Date
- CGBD 05-06-2025
- RXST 05-07-2025
- Dividend Yield
- CGBD 12.94%
- RXST N/A
- EPS Growth
- CGBD N/A
- RXST N/A
- EPS
- CGBD 1.31
- RXST N/A
- Revenue
- CGBD $225,447,000.00
- RXST $148,310,000.00
- Revenue This Year
- CGBD $4.34
- RXST $24.14
- Revenue Next Year
- CGBD $2.48
- RXST $21.47
- P/E Ratio
- CGBD $10.48
- RXST N/A
- Revenue Growth
- CGBD N/A
- RXST 46.70
- 52 Week Low
- CGBD $13.12
- RXST $13.50
- 52 Week High
- CGBD $18.74
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- CGBD 35.35
- RXST 32.41
- Support Level
- CGBD $13.32
- RXST $13.72
- Resistance Level
- CGBD $14.95
- RXST $15.41
- Average True Range (ATR)
- CGBD 0.40
- RXST 0.90
- MACD
- CGBD -0.02
- RXST 0.28
- Stochastic Oscillator
- CGBD 19.13
- RXST 1.00
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.